Affinity Asset Advisors, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
Affinity Asset Advisors, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |